Matthew J Roden

age ~44

from Nicholasville, KY

Also known as:
  • Matthew Joseph Roden
  • Matt J Roden
  • Michael E Roden
Phone and address:
306 Lindleigh Dr, Nicholasville, KY 40356
8593513768

Matthew Roden Phones & Addresses

  • 306 Lindleigh Dr, Nicholasville, KY 40356 • 8593513768
  • Abingdon, VA
  • Raleigh, NC
  • Charleston, SC
  • Morrisville, NC
  • Durham, NC
  • Burlington, NC
  • Corry, PA
  • Conway, SC
  • Lewiston, ID
  • 722 Bent Hickory Rd, Charleston, SC 29414

Work

  • Company:
    Transylvania university
    Aug 2019
  • Position:
    Head cross country and track and field coach

Education

  • Degree:
    Masters
  • School / High School:
    California University of Pennsylvania
    2007 to 2009
  • Specialities:
    Sports Management

Industries

Higher Education

Specialities

Motorcycle Accident
Name / Title
Company / Classification
Phones & Addresses
Matthew Roden
Principal
Mvr Enterprises
Business Services

Resumes

Matthew Roden Photo 1

Head Cross Country And Track And Field Coach

view source
Location:
Nicholasville, KY
Industry:
Higher Education
Work:
Transylvania University
Head Cross Country and Track and Field Coach

Transylvania University Oct 2018 - Jul 2019
Assistant Track and Field Coach

Emory & Henry College Sep 2017 - Aug 2018
Interim Head Track and Field Coach

Medical University of South Carolina Jan 2015 - Jul 2016
Program Coordinator Ii

Ecpi University Jan 2014 - Dec 2014
Admissions Counselor
Education:
California University of Pennsylvania 2007 - 2009
Masters, Sports Management
University of North Carolina Wilmington 2003 - 2005
Bachelors, Business Administration, Management, Business Administration and Management
Coastal Carolina University 2000 - 2003

Lawyers & Attorneys

Matthew Roden Photo 2

Matthew Roden - Lawyer

view source
Specialties:
Motorcycle Accident
ISLN:
1000110584
Admitted:
2017
University:
University of Alabama School of Law
Law School:
University of Alabama School of Law, JD - Juris Doctor, 2016

Googleplus

Matthew Roden Photo 3

Matthew Roden

Matthew Roden Photo 4

Matthew Roden

News

Amgen's osteoporosis drug 'romo' comes through with promising PhIII

view source
  • "Assuming the data are competitive, we think romo will be commercially attractive given its monthly dosing, its differentiated data on cortical bone, and potentially the lack of a black box warning for osteosarcoma that is on Forteo's label (and likely abaloparatide's)," noted UBS's Matthew Roden in
  • Date: Feb 22, 2016
  • Category: Health
  • Source: Google

FDA asks experts to weigh in on PCSK9 drugs' market reach for Amgen ...

view source
  • "We think it's a positive that the documents didn't attempt to exclude patients from the label," UBS's Matthew Roden noted after the Praluent documents surfaced, "but it doesn't settle the debate on how big the class will be."
  • Date: Jun 08, 2015
  • Category: Health
  • Source: Google
Fda Weighs Approval Of First-In-Class Cholesterol Drug

FDA Weighs Approval of First-in-Class Cholesterol Drug

view source
  • Despite the questions raised by the FDA's review, analysts continue to expect the drug win approval. UBS analyst Matthew Roden said in a research note there were "no downside surprises" in the FDA document.
  • Date: Jun 05, 2015
  • Category: Health
  • Source: Google
The Gilead Effect: Pcsk9 Rivals Amgen, Sanofi/Regeneron Prep For A Price War

The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war

view source
  • "We do not see significant risk to approval," UBS analyst Matthew Roden commented a few weeks ago. "Rather, we expect the key debate for the panels to be labelled indications to dictate the most appropriate patient subpopulations for treatment."
  • Date: May 26, 2015
  • Category: Health
  • Source: Google
Fda Review Challenges Vertex's Case For Crucial Cystic Fibrosis Combo

FDA review challenges Vertex's case for crucial cystic fibrosis combo

view source
  • The conclusions may "make for bad headlines," writes UBS biotech analyst Matthew Roden, "but do not represent significant fundamental risk, in our view. The FDA is questioning [1] the clinical meaningfulness of the combo in Fdel508, [2] whether ivacaftor alone would be sufficient for Fdel508, and [
  • Date: May 08, 2015
  • Category: Health
  • Source: Google
Fda Approves New Type Of Heart Failure Drug From Amgen

FDA approves new type of heart failure drug from Amgen

view source
  • "It looks like it's going to help a good number of heart failure patients" here, said UBS Securities biotech analyst Matthew Roden. "Heart failure is a rapidly growing category (that) definitely needs additional options."
  • Date: Apr 15, 2015
  • Category: Health
  • Source: Google
Market-Moving News And Views, 24 Hours A Day

Market-moving news and views, 24 hours a day

view source
  • Matthew Roden, a pharmaceutical analyst at UBS, said the reduction from Gilead would act as a "a headline negative for the sector." And shares of developers of rival hepatitis C treatments like AbbVie, Achillion Pharmaceuticals and Regulus Therapeutics all dropped too.
  • Date: Feb 04, 2015
  • Category: Business
  • Source: Google
Akebia's Lead Drug Succeeds In Mid-Stage Trial

Akebia's lead drug succeeds in mid-stage trial

view source
  • UBS analyst Matthew Roden said the drug, if successful, has blockbuster potential. "We expected AKB-6548 to be well-positioned among competitors due to attractive once-daily dosing ...," he wrote in a note to clients.
  • Date: Oct 27, 2014
  • Category: Health
  • Source: Google

Youtube

Is Temptation is a fact of life? - Hunted - E...

Temptation is a fact of life for the faithful, but God can prepare us ...

  • Duration:
    34m 10s

Behind the Music | "MORE" with Matt Roden

Listen to the song: We just released a new song "MORE" by Friends Wo...

  • Duration:
    27m 30s

Mega Church vs Small Church Insights from a ...

Today's podcast is with my friend Pastor Matt Roden. Matt has served l...

  • Duration:
    59m 34s

The Storm Approaches - Pastor Matt Roden

Storms come to everyone whether we are prepared or not, but they don't...

  • Duration:
    35m 26s

Trash Talk - Words - Matt Roden

Our words have the power to build up or tear down, and how we use them...

  • Duration:
    33m 53s

Codebreakers: Hard Conversations - Pastor Mat...

We can't avoid hard conversations, but with we can learn to navigate t...

  • Duration:
    31m 41s

Myspace

Matthew Roden Photo 5

Matthew van Roden Free M...

view source
Matthew van Roden's official profile including the latest music, albums, songs, music videos and more updates.
Matthew Roden Photo 6

Matthew Roden

view source
Gender:
Male
Birthday:
1941

Flickr

Classmates

Matthew Roden Photo 14

Matthew Roden Cranst Hig...

view source
Matthew Roden 1985 graduate of Cranston High School East in Cranston, RI is on Memory Lane. Get caught up with Matthew and other high school alumni from
Matthew Roden Photo 15

Matt Roden | McMinnville ...

view source
Matthew Roden Photo 16

Matt Roden | Webster City...

view source
Matthew Roden Photo 17

Carrollton Junior High Sc...

view source
Graduates:
John Hillis (1982-1986),
Kimberly Sutton (1997-2000),
Rosa Velez (2000-2004),
Matt Roden (2000-2004)
Matthew Roden Photo 18

McMinnville High School, ...

view source
Graduates:
Matt Roden (1991-1995),
Vance Reeves (1984-1988),
Miriam Arciga (1990-1994),
Mary Lynn Alexander (1961-1965),
Daniel Brayton (1973-1977)

Facebook

Matthew Roden Photo 19

Matthew Roden

view source
Matthew Roden Photo 20

Matthew Roden

view source
Matthew Roden Photo 21

Matthew Roden

view source
Matthew Roden Photo 22

Matt Roden

view source
Matthew Roden Photo 23

Matthew James Roden

view source
Matthew Roden Photo 24

Matthew Roden

view source
Matthew Roden Photo 25

Matthew Roden

view source
Matthew Roden Photo 26

James Matthew Roden

view source

Get Report for Matthew J Roden from Nicholasville, KY, age ~44
Control profile